scholarly journals The Utility of Rapid On-Site Evaluation on Endobronchial Ultrasound Guided Transbronchial Needle Aspiration: Does It Make a Difference?

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Raymond W. M. Wong ◽  
Alesha Thai ◽  
Yet H. Khor ◽  
Kerryn Ireland-Jenkin ◽  
Celia J. Lanteri ◽  
...  

The purpose of this study was to assess the efficacy of using rapid on-site evaluation (ROSE) for samples taken during endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) at Austin Health, Victoria. This was compared to data collected for cases performed without ROSE. A retrospective analysis was conducted on 188 consecutive patients who underwent EBUS-TBNA from May 2012 to July 2014 whose data was collected prospectively at the time of the procedure. The presence of a cytologist during ROSE resulted in a significant reduction in the number of lesions sampled [mean: 1.5 ± 0.7 (1, 4) versus 1.9 ± 0.8 (1, 4), P = 0.0020] and the number of TBNAs required per case [mean: 3.6 ± 1.4 (1, 8) versus 4.2 ± 1.5 (1, 8), P = 0.0017]. This could potentially result in a shorter procedure time and, ultimately, a reduction in complication rate. The quality of the samples obtained during EBUS-TBNA with ROSE was higher. A larger proportion of samples yielded a satisfactory cell block allowing the potential benefit of additional pathology testing including immunohistochemistry and molecular pathology. In summary, the use of ROSE during EBUS-TBNA was superior to off-site cytological assessment of bronchoscopy specimens.

Author(s):  
Cristina Caupena ◽  
Lluis Esteban ◽  
Angels Jaen ◽  
Bienvenido Barreiro ◽  
Raquel Albero ◽  
...  

Abstract Objectives In patients with lung cancer undergoing mediastinal staging through endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), decisions are based on rapid on-site evaluation (ROSE) findings. We aimed to analyze the concordance rate between ROSE diagnosis and final diagnosis. Methods A prospective study was carried out in patients undergoing EBUS-TBNA for lung cancer staging. Diagnosis concordance was defined as cases where lymph nodes (LNs) presented the same diagnosis in ROSE and final diagnosis. Determinants of concordance were analyzed. Results Sixty-four patients were included and 637 LNs sampled. ROSE diagnosis was concordant with final diagnosis in 612 (96.1%) LNs and nonconcordant in 25 (3.9%). Differences in the concordance rate were found between pathologists, ROSE diagnoses, presence of cell block, number of passes, and number of slides. The staging status was changed between ROSE and the final diagnosis in three (4.6%) patients. Conclusions ROSE diagnosis has a high concordance with the final diagnosis.


2019 ◽  
Author(s):  
Keigo Uchimura ◽  
Kei Yamasaki ◽  
Sachika Hara ◽  
Takashi Tachiwada ◽  
Toshinori Kawanami ◽  
...  

Abstract Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a standard method for obtaining specimens of mediastinal and hilar lesions, and several types of needle of various sizes and materials are available. This study aimed to compare the utility and safety of two needles, cobalt chromium (CC) and stainless steel (SS), for EBUS-TBNA. Methods: This retrospective study included data of patients who underwent EBUS-TBNA with a 22-gauge needle made from either SS (38 patients, 121 punctures) or CC (39 patients, 145 punctures), and procedure time, histological data, complication rates were compared. Results: There were no significant differences between the groups in the baseline characteristics of the patients or lesions or in the complication rates. Although diagnostic yields in each patient who underwent EBUS-TBNA with the two needle types were similar, significantly shorter procedure time (22 min vs. 26 min, p = 0.007), diagnostic histologic sampling yield in each sample (71.0% vs. 58.7%, p = 0.039), fewer samples with cartilage alone (1.4% vs. 6.6%, p = 0.047) and fewer samples containing cartilage (7.6% vs. 16.5%, p = 0.034) were seen in the CC group compared with that in SS needle group. Conclusion: Compared with SS needles, CC needle for EBUS-TBNA showed significant shorter procedure time and higher ratio of getting diagnostic histological specimens in each sample. This might be because of better ability of CC needle to puncture through the trachea and bronchial cartilage to get appropriate lymph node sampling.


CytoJournal ◽  
2011 ◽  
Vol 8 ◽  
pp. 20 ◽  
Author(s):  
Adrienne Carruth Griffin ◽  
Lauren Ende Schwartz ◽  
Zubair W. Baloch

Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an integral tool in the diagnosis and staging of malignant tumors of the lung. Rapid on-site evaluation (ROSE) of fine needle aspiration (FNA) samples has been advocated for as a guide for assessing the accuracy and adequacy of biopsy samples. Although ROSE has proven useful for numerous sites and procedures, few studies have specifically investigated its utility in the assessment of EBUS-TBNA specimens. The intention of this study was to explore the utility of ROSE for EBUS-TBNA specimens. Materials and Methods: The pathology files at our institution were searched for all EBUS-TBNA cases performed between January 2010 and June 2010. The data points included number of sites sampled per patient, location of site(s) sampled, on-site evaluation performed, preliminary on-site diagnosis rendered, final cytologic diagnosis, surgical pathology follow-up, cell blocks, and ancillary studies performed. Results: A total of 294 EBUS-TBNA specimens were reviewed and included in the study; 264 of 294 (90%) were lymph nodes and 30 of 294 (10%) were lung mass lesions. ROSE was performed for 140 of 294 (48%) specimens. The on-site and final diagnoses were concordant in 104 (74%) and discordant in 36 (26%) cases. Diagnostic specimens were obtained in 132 of 140 (94%) cases with on-site evaluation and 138 of 154 (90%) without on-site evaluation. The final cytologic diagnosis was malignant in 60 of 132 (45%) cases with ROSE and 46 of 138 (33%) cases without ROSE, and the final diagnosis was benign in 57 of 132 (47%) with ROSE and 82 of 138 (59%) without ROSE. A cell block was obtained in 129 of 140 (92%) cases with ROSE and 136 of 154 (88%) cases without ROSE. Conclusions: The data demonstrate no remarkable difference in diagnostic yield, the number of sites sampled per patient, or clinical decision making between specimens collected via EBUS-TBNA with or without ROSE. As a result, this study challenges the notion that ROSE is beneficial for the evaluation of EBUS-TBNA specimens.


CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A1069-A1070
Author(s):  
Mushtaq Ahmad ◽  
Merlin Thomas ◽  
Mansoor Hameed ◽  
Abbas Alabbas ◽  
Mustafa Akram Yousif Al-Tikrity ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document